Donald Healey
Technik-/Wissenschafts-/F&E-Leiter bei ADICET BIO, INC.
Vermögen: 63 764 $ am 30.04.2024
Profil
Donald Healey is currently the Chief Technology Officer at Adicet Bio, Inc. He was previously the Senior Vice President-Operations at KBI Biopharma, Inc. from 2017 to 2020 and the Chief Scientific Officer at Opexa Therapeutics, Inc. from 2013 to 2017.
He also worked as the Director-Immunology at Argos Therapeutics, Inc. and as a Council Member at the British Society for Immunology.
He holds a doctorate degree from the University of London and an undergraduate degree from the University of Bristol.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ADICET BIO INC
0,04% | 09.04.2024 | 35 229 ( 0,04% ) | 63 764 $ | 30.04.2024 |
Aktive Positionen von Donald Healey
Unternehmen | Position | Beginn |
---|---|---|
ADICET BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.10.2020 |
Ehemalige bekannte Positionen von Donald Healey
Unternehmen | Position | Ende |
---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Geschäftsführer | 01.10.2020 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Corporate Officer/Principal | 01.01.1998 |
ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Donald Healey
University of Bristol | Undergraduate Degree |
University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADICET BIO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Commercial Services |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Commercial Services |